Protein H1.0 stops cancer cells re-activating

An international study led by scientists from the Hebrew University of Jerusalem and the Crick Institute in London has revealed that cancer stem cells survive even after aggressive treatments. However, they need low (or zero) levels of a DNA-packaging protein H1.0 to re-activate.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *